Diverse effects of bacterial cell wall components on mast cell degranulation, cysteinyl leukotriene generation and migration.
Nowadays there is more and more evidence that mast cells take part in antibacterial defence. Mast cells have the ability to kill bacteria via phagocytose-dependent or phagocytose-independent ways and express antimicrobial peptides that can directly kill pathogens at their site of entry. What is more, mast cells are capable of processing bacterial antigens for presentation through class I and II MHC molecules. Some data indicate that these cells can release various proinflammatory mediators in response to activation with bacteria and/or their products, however this information is still far from complete. Therefore, in this study we examined the ability of PGN from Staphylococcus aureus, LPS from Eschericha coli and LAM from Mycobacterium smegmatis to stimulate mature rat mast cell degranulation as well as cysteinyl LT generation. We also studied the influence of these bacterial components on mast cell migration. We found that PGN, LPS and LAM all failed to induce mast cell degranulation and histamine release. At the same time, activation of mast cells with these bacterial antigens resulted in generation and release of significant amounts of LT. Moreover, we documented that, even in the presence of laminin, none of the bacterial antigens used stimulated mast cell migration. However, PGN did induce migration of RANTES-primed mast cells, and LPS did stimulate mast cell migratory response after priming with IL-6. Our results show that PGN, LPS and LAM might be among the important bacterial antigens involved in mast cell activation during bacterial infection.
Wierzbicki
Maciej
M
Department of Experimental Immunology, Medical University of Łódź, Łódź, Poland.
Brzezińska-Błaszczyk
Ewa
E
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002465:Cell Movement / Q000502:physiology*; D003545:Cysteine / Q000096:biosynthesis* / Q000378:metabolism; D004926:Escherichia coli / Q000502:physiology*; D005260:Female; D006636:Histamine Release / Q000502:physiology*; D015289:Leukotrienes / Q000096:biosynthesis* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects / Q000382:microbiology*; D020102:Mycobacterium smegmatis / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D013211:Staphylococcus aureus / Q000502:physiology*
D015289:Leukotrienes; D008070:Lipopolysaccharides; C112381:cysteinyl-leukotriene; C050016:lipoarabinomannan; D000001:Calcimycin; D003545:Cysteine